Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis

Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis David Gould, Nasim Yousaf, Rewas Fatah, Maria Cristina Subang and Yuti Chernajovsky Bone and Joint Research Unit, Barts and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, University of London, London, EC1M 6BQ, UK Corresponding author: David Gould, d.j.gould@qmul.ac.uk Received: 25 Sep 2006 Revisions requested: 26 Oct 2006 Revisions received: 20 Dec 2006 Accepted: 25 Jan 2007 Published: 25 Jan 2007 Arthritis Research & Therapy 2007, 9:R7 (doi:10.1186/ar2113) This article is online at: http://arthritis-research.com/content/9/1/R7 © 2007 Gould et al.; licensee BioMed Central Ltd....